0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
Back
DONATE
  • Patient Videos & Webinars,
• 8/7/24

Module 2: The Therapeutic Potential of Increasing RUNX1 Activity Using a Drug

This module describes how medications could reduce RUNX1-FPD symptoms and potentially cancer risk as well.

Previous

Module 1 - Seeds, Weeds and RUNX1-FPD: Understanding Blood Cancer Development

Next

Module 3: The Potential Promise and Current Challenges of Gene Editing

You Might Also Like

Related Embedded Video Item Thumbnail RUNX1-FPD and NIH Study Intro
Related Embedded Video Item Thumbnail "Mechanisms underlying aging associated increased heterogeneity and selection for clonal hematopoiesis mutations in hematopoietic stem cell pools."
Related Embedded Video Item Thumbnail RUNX1 Deficiency in Megakaryopoiesis: Discovering Therapeutics for RUNX1 Haploinsufficiency
Related Embedded Video Item Thumbnail Introduction to the RUNX1-FPD Sirolimus Pilot Study (6.24.24)
Related Embedded Video Item Thumbnail Intro to PCOR - Defining it for the RUNX1-FPD Community

Sign Up For Our Email List!

Enter your information below to receive the
latest RUNX1 news and updates!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
SHOP